Physician profile
Cedric Wong
NPI 1396702684
$2,684.99
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $825 · 2020: $1,380 · 2021: $331 · 2024: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $148.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $148.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, LP | $1,176.50 | 2020 | |
| Stryker Corporation | $352.02 | 2019-2024 | Inspace |
| Pacira Therapeutics, INC. | $307.28 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $143.67 | 2019-2021 | |
| Medical Device Business Services, INC. | $125.05 | 2019 | |
| Fidia Pharma USA INC. | $118.90 | 2019 | |
| Depuy Synthes Sales INC. | $77.02 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $63.84 | 2019-2020 | |
| Bone Support INC. | $53.47 | 2019 | |
| Bioventus LLC | $52.36 | 2019-2020 | |
| Fx Shoulder Solutions, INC | $39.31 | 2019 | |
| Ibsa Pharma INC. | $32.38 | 2021 | |
| Daiichi Sankyo INC. | $25.19 | 2019-2021 | |
| Smith+Nephew, INC. | $21.05 | 2021 | |
| Davol INC. | $20.79 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $19.76 | 2020 | |
| Acell, INC. | $15.78 | 2019 | |
| Conformis, INC. | $15.32 | 2019 | |
| Zyla Life Sciences, INC. | $13.17 | 2020 | |
| Integra Lifesciences Corporation | $12.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cedric Wong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.